Gut microbiome is not associated with mild cognitive impairment in Parkinson’s disease

Velma T.E. Aho*, Zied Landoulsi, Rejko Krüger, Geeta Acharya, Gloria Aguayo, Myriam Alexandre, Wim Ammerlaan, Roxane Batutu, Katy Beaumont, Sibylle Béchet, Guy Berchem, Ibrahim Boussaad, Gessica Contesotto, Nancy De Bremaeker, Angelo Ferrari, Joëlle Fritz, Carlos Gamio, Manon Gantenbein, Laura Georges, Marijus GiraitisJérôme Graas, Anne Marie Hanff, Estelle Henry, Margaux Henry, Alexander Hundt, Sonja Jónsdóttir, Jochen Klucken, Olga Kofanova, Pauline Lambert, Ana Festas Lopes, Victoria Lorentz, Tainá M. Marques, Guilherme Marques, Deborah Mcintyre, Chouaib Mediouni, Alexia Mendibide, Myriam Menster, Michel Mittelbronn, Saïda Mtimet, Maeva Munsch, Ulf Nehrbass, Sarah Nickels, Fozia Noor, Claire Pauly, Laure Pauly, Lukas Pavelka, Magali Perquin, Achilleas Pexaras, Armin Rauschenberger, Lucie Remark, Ilsé Richard, Olivia Roland, Stefano Sapienza, Amir Sharify, Kate Sokolowska, Maud Theresine, Hermann Thien, Johanna Trouet, Michel Vaillant, Carlos Vega, Gelani Zelimkhanov, on behalf of the NCER-PD Consortium

*Corresponding author for this work

Research output: Contribution to journalArticleResearchpeer-review

Abstract

Gut microbiome differences between people with Parkinson’s disease (PD) and control subjects without Parkinsonism are widely reported, but potential alterations related to PD with mild cognitive impairment (MCI) have yet to be comprehensively explored. We compared gut microbial features of PD with MCI (n = 58) to cognitively unimpaired PD (n = 60) and control subjects (n = 90) with normal cognition. Our results did not support a specific microbiome signature related to MCI in PD.

Original languageEnglish
Article number78
Journalnpj Parkinson's Disease
Volume10
Issue number1
DOIs
Publication statusPublished - 6 Apr 2024

Fingerprint

Dive into the research topics of 'Gut microbiome is not associated with mild cognitive impairment in Parkinson’s disease'. Together they form a unique fingerprint.

Cite this